OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
Clinical trial NCT01478542 · COMPLETED
Trial details
- NCT number
- NCT01478542
- Sponsor
- Universität des Saarlandes
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2024-01-18
- Enrollment
- 1152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.